ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,183.30
0.45%
Dow Jones
38,386.09
0.00%
Gold vs US Dollar
2,307.77
-1.11%
Brent Oil
87.635
0.40%
Bitcoin
61,187.61
-4.15%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Bayer Ord (BYR)

  7. Bayer Ord (BYR) News

Bayer Ord (BYR)

Bayer Ord
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:BYR
DateTimeSourceHeadlineSymbolCompany
05/03/202412:17Alliance NewsAlliance NewsUPDATE: Bayer denies split-up as "not now" while swings to annual lossLSE:BYRBayer Ord
05/03/202410:13Alliance NewsAlliance NewsTOP NEWS: Bayer swings to annual loss on falling sales as costs riseLSE:BYRBayer Ord
04/03/202409:35Alliance NewsAlliance NewsBayer acquires European marketing rights to acoramidis heart treatmentLSE:BYRBayer Ord
19/02/202418:17Alliance NewsAlliance NewsTOP NEWS: Bayer slashes dividend in commitment to cutting down debtLSE:BYRBayer Ord
13/02/202417:07Alliance NewsAlliance NewsIN BRIEF: Bayer notes first patient in GenePHIT trialLSE:BYRBayer Ord
18/01/202406:09Alliance NewsAlliance NewsChemical firm Bayer confirms 'significant' workforce cuts in GermanyLSE:BYRBayer Ord
11/01/202414:29Alliance NewsAlliance NewsCORRECT: RTW Biotech's manager invests USD127 million in Ji XingLSE:BYRBayer Ord
08/01/202418:12Alliance NewsAlliance NewsBayer reports progress on two fronts for menopausal drug, elinzanetantLSE:BYRBayer Ord
08/01/202412:27Alliance NewsAlliance NewsRTW Biotech Opportunities invests USD127 million in investee Ji XingLSE:BYRBayer Ord
19/12/202305:52Alliance NewsAlliance NewsBayer's Monsanto to pay USD857 million over chemicals in schoolLSE:BYRBayer Ord
20/11/202310:51Alliance NewsAlliance NewsTOP NEWS: Bayer stock plunges on study blow for blood thinnerLSE:BYRBayer Ord
08/11/202308:40Alliance NewsAlliance NewsTOP NEWS: Bayer considers splitting up as quarterly loss balloonsLSE:BYRBayer Ord
01/11/202312:41Alliance NewsAlliance NewsBayer loses third consecutive US damages trial over Roundup weedkillerLSE:BYRBayer Ord
08/08/202308:03Alliance NewsAlliance NewsTOP NEWS: Bayer loss widens to nearly EUR2 billion on glyphosate hitLSE:BYRBayer Ord
24/07/202320:26Alliance NewsAlliance NewsTOP NEWS: Bayer cuts guidance on lower prices of glyphosate productsLSE:BYRBayer Ord
05/06/202311:39Alliance NewsAlliance NewsIN BRIEF: Bayer partners with Acquitas on lipid nanoparticle techLSE:BYRBayer Ord
11/05/202312:21Alliance NewsAlliance NewsTOP NEWS: Bayer shares fall as sales suffer on lower pricingLSE:BYRBayer Ord
28/02/202311:09Alliance NewsAlliance NewsBayer sees strong performance over 2022 but cautious over inflationLSE:BYRBayer Ord
10/02/202310:54Alliance NewsAlliance NewsIN BRIEF: Bayer's Kerendia granted label update by European CommissionLSE:BYRBayer Ord
08/02/202319:13Alliance NewsAlliance NewsTOP NEWS: Bayer appoints Bill Anderson as new chief executiveLSE:BYRBayer Ord
23/01/202311:02Alliance NewsAlliance NewsBayer's Ultravist wins contrast-enhanced mammography approval in EULSE:BYRBayer Ord
10/11/202211:10Alliance NewsAlliance NewsBayer buys German biotechnology start-up TargenomixLSE:BYRBayer Ord
09/09/202206:40Alliance NewsAlliance NewsRegeneron shares surge on positive Eylea trial dataLSE:BYRBayer Ord
12/08/202212:02Alliance NewsAlliance NewsTribunal rules against BASF in seed businesses dispute with BayerLSE:BYRBayer Ord
04/08/202208:48Alliance NewsAlliance NewsTOP NEWS: Legal woes hit Bayer's profit in second quarterLSE:BYRBayer Ord
21/06/202221:53Alliance NewsAlliance NewsUS high court denies Bayer bid to block Roundup weedkiller lawsuitsLSE:BYRBayer Ord
10/05/202208:00Alliance NewsAlliance NewsTOP NEWS: Bayer makes good start to 2022 with strong quarterly salesLSE:BYRBayer Ord
22/04/202212:16Alliance NewsAlliance NewsIN BRIEF: Bayer seeks further approval for darolutamide in ChinaLSE:BYRBayer Ord
04/04/202219:09Alliance NewsAlliance NewsIN BRIEF: Bayer notes positive new data for finerenoneLSE:BYRBayer Ord
31/03/202210:24Alliance NewsAlliance NewsBayer to invest EUR2 billion to strengthen pharmaceutical divisionLSE:BYRBayer Ord
 Showing the most relevant articles for your search:LSE:BYR

Your Recent History

LSE
SOLG
Solgold
LSE
SYME
Supply@me Capital
LSE
GGP
Greatland Gold
LSE
MIN
Minoan
LSE
POS
Plexus
LSE
PFC
Petrofac
LSE
BOO
Boohoo
LSE
DELT
Deltic Energy
LSE
AAZ
Anglo Asian Mining
LSE
VAST
Vast Resources
LSE
CARD
Card Factory
LSE
TERN
Tern
LSE
TRP
Tower Resources
LSE
AAU
Ariana Resources
LSE
AXL
Arrow Exploration
LSE
OXB
Oxford Biomedica
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved